Skip to main content
Veterinary Medicines

Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
Bupaq Multidose 0,3 mg/ml Injektionslösung für Hunde und Katzen
Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 10 ml
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 10 x 10 ml
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA23462/003/001
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0008/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)